Seqanswers Leaderboard Ad

Collapse

Announcement

Collapse
No announcement yet.
X
 
  • Filter
  • Time
  • Show
Clear All
new posts

  • AI-Driven Analysis of Tumor Genetics Enhances Chemotherapy Prediction

    Click image for larger version  Name:	Low-Res_national-cancer-institute-jdfn7Z03Qa4-unsplash.jpg Views:	0 Size:	178.1 KB ID:	325404
    Cervical cancer, shown here at the cellular level, frequently resists treatment. The researchers’ machine learning algorithm could help scientists better understand why this and other forms of cancer resist chemotherapy. (Image Credit: National Cancer Institute​)




    In a recent article published in Cancer Discovery, a team from the University of California San Diego School of Medicine reported on the development of a machine learning algorithm designed to predict cancer resistance to chemotherapy. This research addresses a critical challenge in oncology: anticipating when cancer will resist treatment.

    Understanding Cancer Resistance Through AI
    The study focuses on the role of a tumor's genetic makeup in determining its response to chemotherapy, particularly drugs targeting DNA replication in cancer cells. The complexity of the mutations within tumors has historically made predicting drug resistance difficult. However, the newly developed algorithm surmounts this challenge by examining how various genetic mutations collectively affect a tumor’s reaction to chemotherapy agents.

    The team tested this model specifically on cervical cancer tumors, assessing their responses to cisplatin. The model could not only pinpoint tumors most likely to resist treatment but also identify key elements of the molecular machinery that drive this resistance.

    Insights from the Researchers
    Dr. Trey Ideker, a professor in the Department of Medicine at UC San Diego, emphasized the importance of understanding a broad spectrum of mutations. "Clinicians were previously aware of a few individual mutations that are associated with treatment resistance, but these isolated mutations tended to lack significant predictive value. The reason is that a much larger number of mutations can shape a tumor's treatment response than previously appreciated," Ideker explained. He added, "Artificial intelligence bridges that gap in our understanding, enabling us to analyze a complex array of thousands of mutations at once."

    A significant hurdle in comprehending drug effects on tumors lies in the inherent sophistication of the DNA replication process, which is frequently targeted by cancer medications. “Hundreds of proteins work together in complex arrangements to replicate DNA," Ideker stated. "Mutations in any one part of this system can change how the entire tumor responds to chemotherapy.”

    The Machine Learning Approach
    The research team used a standard set of 718 genes, typically employed in clinical genetic testing for cancer, as the initial data input for their algorithm. After training the model with publicly available drug response data, it identified 41 molecular assemblies where genetic alterations influence drug efficacy.

    Ideker highlighted the network-based nature of cancer and the limitations of previous models. "Rather than focusing on a single gene or protein, our model evaluates the broader biochemical networks vital for cancer survival," he said.

    Testing and Transparency of the Model
    When applied to cervical cancer, the model accurately identified tumors likely to respond positively to treatment and those prone to resistance. Importantly, the model also offers insights into its decision-making process by pinpointing the protein assemblies driving treatment resistance.

    "Unraveling an AI model's decision-making process is crucial, sometimes as important as the prediction itself," Ideker remarked. He sees the model's transparency as a significant strength, building trust in the AI system and identifying potential new targets for chemotherapy.

    This AI-driven approach not only enhances the prediction of chemotherapy outcomes but also opens avenues for developing new treatment strategies. While optimistic about the broad applications of their model, the researchers maintain a cautious approach, focusing on the practical and immediate benefits of this technology in enhancing current cancer treatments.

    Original Publication
    Xiaoyu Zhao, Akshat Singhal, Sungjoon Park, JungHo Kong, Robin Bachelder, Trey Ideker; Cancer mutations converge on a collection of protein assemblies to predict resistance to replication stress. Cancer Discov 2024; https://doi.org/10.1158/2159-8290.CD-23-0641

Latest Articles

Collapse

  • seqadmin
    The Impact of AI in Genomic Medicine
    by seqadmin



    Artificial intelligence (AI) has evolved from a futuristic vision to a mainstream technology, highlighted by the introduction of tools like OpenAI's ChatGPT and Google's Gemini. In recent years, AI has become increasingly integrated into the field of genomics. This integration has enabled new scientific discoveries while simultaneously raising important ethical questions1. Interviews with two researchers at the center of this intersection provide insightful perspectives into...
    02-26-2024, 02:07 PM
  • seqadmin
    Multiomics Techniques Advancing Disease Research
    by seqadmin


    New and advanced multiomics tools and technologies have opened new avenues of research and markedly enhanced various disciplines such as disease research and precision medicine1. The practice of merging diverse data from various ‘omes increasingly provides a more holistic understanding of biological systems. As Maddison Masaeli, Co-Founder and CEO at Deepcell, aptly noted, “You can't explain biology in its complex form with one modality.”

    A major leap in the field has
    ...
    02-08-2024, 06:33 AM

ad_right_rmr

Collapse

News

Collapse

Topics Statistics Last Post
Started by seqadmin, 02-28-2024, 06:12 AM
0 responses
28 views
0 likes
Last Post seqadmin  
Started by seqadmin, 02-23-2024, 04:11 PM
0 responses
74 views
0 likes
Last Post seqadmin  
Started by seqadmin, 02-21-2024, 08:52 AM
0 responses
83 views
0 likes
Last Post seqadmin  
Started by seqadmin, 02-20-2024, 08:57 AM
0 responses
69 views
0 likes
Last Post seqadmin  
Working...
X